InsiderClue
Insiders · Profile

LaBrosse Nicole

SVP, CHIEF FINANCIAL OFFICER at HALOZYME THERAPEUTICS. Filing since 15 Nov 2022. CIK 0001910662

Company
Date
Role
Action
Shares
Amount
Of holding
HALO HALOZYME THERAPEUTICS, INC.
22 Sep 2025
SVP, CHIEF FINANCIAL OFFICER
Sold on a plan
2,227
$173.58K
9.2%
HALO HALOZYME THERAPEUTICS, INC.
10 Sep 2025
SVP, CHIEF FINANCIAL OFFICER
Sold on a plan
20,000
$1.51M
45.1%
HALO HALOZYME THERAPEUTICS, INC.
22 Jul 2024
SVP, CHIEF FINANCIAL OFFICER
Sold on a plan
5,000
$269.66K
24.4%
HALO HALOZYME THERAPEUTICS, INC.
28 Jun 2024
SVP, CHIEF FINANCIAL OFFICER
Sold on a plan
10,000
$520.40K
39.2%
HALO HALOZYME THERAPEUTICS, INC.
27 Jun 2024
SVP, CHIEF FINANCIAL OFFICER
Sold on a plan
10,000
$519.34K
39.2%
HALO HALOZYME THERAPEUTICS, INC.
26 Jun 2024
SVP, CHIEF FINANCIAL OFFICER
Sold on a plan
10,000
$518.20K
39.2%
HALO HALOZYME THERAPEUTICS, INC.
16 Feb 2023
SVP, CHIEF FINANCIAL OFFICER
Sold, plan not stated
2,525
$124.38K
21.8%
HALO HALOZYME THERAPEUTICS, INC.
15 Nov 2022
SVP, CHIEF FINANCIAL OFFICER
Sold, plan not stated
5,000
$269.05K
55.3%
8 decisions on file.